反応式
[CH2:1]([C:12]1[CH:13]=[N:14][C:15]([C:18]2[CH:23]=[CH:22][C:21]([OH:24])=[CH:20][CH:19]=2)=[N:16][CH:17]=1)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH3:11].[CH2:25]([C:28]1[S:29][C:30]([C:33](O)=[O:34])=[CH:31][N:32]=1)[CH2:26][CH3:27].C1(N=C=NC2CCCCC2)CCCCC1>ClCCl>[CH2:1]([C:12]1[CH:13]=[N:14][C:15]([C:18]2[CH:19]=[CH:20][C:21]([O:24][C:33]([C:30]3[S:29][C:28]([CH2:25][CH2:26][CH3:27])=[N:32][CH:31]=3)=[O:34])=[CH:22][CH:23]=2)=[N:16][CH:17]=1)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH3:11]参加物
5
実験手順
4.9 g of 4-(5-undecyl-pyrimidin-2-yl)phenol, 1.7 g of 2-propyl-thiazole-5-carboxylic acid (prepared as described by Clemence et al., Eur. J. Med. Chem. Chimica Therapeutica 1976-11, no. 6, p. 567–570) and 2.1 g of dicyclohexylcarbodiimide are stirred for 24 h in 50 ml of dichloromethane at room temperature. Filtration, removal of the dichloromethane by distillation, purification by chromatography (silica gel; dichloromethane/heptane) and recrystallization from acetonitrile affords the target compound as colorless crystals.
後処理
- filtrationFiltration, removal of the dichloromethane
- distillationby distillation, purification
- customby chromatography (silica gel; dichloromethane/heptane) and recrystallization from acetonitrile
出典と根拠
- ORDレコード
- ord-38baffec5dba4fe3b5aaf96ad15b37c6
- 出典データセット
- uspto-grants-2006_05
- 特許番号
- US07052742B1
関連ノート
読み込み中…